Spinogenix Reports Positive Initial Results from Phase 2a Alzheimer’s Trial of SPG302

RefinitivWaktu baca kurang dari 1 menit

SPINOGENIX ANNOUNCES POSITIVE FIRST COHORT RESULTS FROM PHASE 2A TRIAL EVALUATING SPG302 FOR ALZHEIMER'S DISEASE

© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html

Masuk atau buat akun gratis selamanya untuk membaca berita ini